Overview

Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the efficacy of the prophylactic treatment with rifaximin to prevent travellers diarrhoea.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Philipp Zanger, MD MSc DTM
Treatments:
Rifamycins
Rifaximin